overdose of semaglutide symptoms GLP-1 medications like and tirzepatide are on the rise, but so are accidental overdoses these medications. Poison control centers have seen a massive surge in calls regarding weight-loss and diabetes FDA alerts health care providers,

Therefore, patients should not assume that every GLP-1 medicine works the same way

Given the relatively older population (median age 69 years), non-cardiovascular mortality over the 4.5-year follow-up period may reduce the number of individuals at risk for cardiovascular events, potentially leading to modest overestimation of projected event rates

management is primarily supportive and focused on addressing underlying causes, as outlined in PCDS guidance

Semaglutide is administered as a subcutaneous injection, which involves injecting the medication into a layer of fat beneath the skin

Contamination Issues : Lower-grade peptides may contain impurities that increase the risk of allergic reactions or unexpected side effects

During the tirzepatide trial, participants experienced an average weight loss of 6.9% after 12 weeks